JNJ
168.27
-0.78%↓
NVS
117.59
+0.37%↑
ABT
126.59
+0.73%↑
MDT
92.9
+0.6%↑
ELV.US
289.29
+3.16%↑
JNJ
168.27
-0.78%↓
NVS
117.59
+0.37%↑
ABT
126.59
+0.73%↑
MDT
92.9
+0.6%↑
ELV.US
289.29
+3.16%↑
JNJ
168.27
-0.78%↓
NVS
117.59
+0.37%↑
ABT
126.59
+0.73%↑
MDT
92.9
+0.6%↑
ELV.US
289.29
+3.16%↑
JNJ
168.27
-0.78%↓
NVS
117.59
+0.37%↑
ABT
126.59
+0.73%↑
MDT
92.9
+0.6%↑
ELV.US
289.29
+3.16%↑
JNJ
168.27
-0.78%↓
NVS
117.59
+0.37%↑
ABT
126.59
+0.73%↑
MDT
92.9
+0.6%↑
ELV.US
289.29
+3.16%↑
24h
Current
Min
5
Max
5.22
Employees | 11 |
---|
Recommendations | Buy |
---|---|
12 Months Forecast | +1668.17% upside |
Market Cap | 15M |
---|---|
Previous open | 8.13 |
Previous close | 5.07 |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
11 gru 2024, 18:44 UTC
Cellectar Biosciences Plunges on Pursuit of Strategic Options for Cancer Drug Candidate, 60% Workforce Cut
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 90 USD 1668.17%
High 90 USD
Low 90 USD
Based on 2 Wall Street analysts offering 12 month price targets forCellectar Biosciences Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
1
Buy
1
Hold
0
Sell
Based on 2 analysts giving stock ratings to Cellectar Biosciences Inc - Dist in the past 3 months.
$